Worth reading
53Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
9492
¥ million (year-on-year increase in revenue)Wording
Conditional
How definitive the wording is.Contents of this document
Earnings presentationSecond quarter of the fiscal year ending March 20277 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥73,520 million+14.8%
Operating profit¥3,478 million+210.8%
Ordinary income¥3,621 million+172.9%
Net income¥1,597 million +84.8%interim net income attributable to owners of the parent
Gross Profit Margin29.7
Operating profit margin4.7
Selling, general and administrative expenses¥18,336 million
Full-year earnings forecast
Operating profit
¥6,000 million
Profit attributable to owners of the parent
¥3,200 million
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Progressing steadilyBreakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
- Increase in revenue¥9,492 million
- Increase in cost of sales¥5,625 million
- Increase in gross profit¥3,866 million
- Higher SG&A Expenses¥1,506 million
- Increase in personnel expenses¥386 million
- Decrease in promotional and advertising expenses¥-138 million
- Increase in general expenses¥1,259 million
New initiatives
- Launch of a global music catalog acquisition project with a total value of approximately USD 100 million
- Additional acquisition of an interest in US artist management company S10 Entertainment & Media
- Major performances and major productions scheduled for the second half of the fiscal year
Key KPIsA metric the company considers important as a management benchmark.
- Total number of performances648 performancesYear on year against the same period last year+65.0%
- Attendance179 10,000 peopleYear on year against the same period last year+30.0%
- Albums sold887 thousand prescriptionsYear on year against the same period last year-221.0%
- Singles sold3,222 thousand prescriptionsYear on year against the same period last year+741.0%
- DVDs/Blu-rays sold839 thousand prescriptionsYear on year against the same period last year-67.0%
Unit price and quantity metricsThese figures show sales broken down by price and volume.
- Average ticket price12,188 yenYear on year against the same period last year-914.0%
- Average album price2,441 yenYear on year against the same period last year+443.0%
- Albums sold887 thousand prescriptionsYear on year against the same period last year-221.0%
- Music package and single-unit price5,833 yenYear on year against the same period last year+583.0%
- Number of music packages and singles3,222 thousand prescriptionsYear on year against the same period last year+741.0%
Segment results
- Music businessNet Sales¥57,927 million (YoY +8.3%)Operating profit¥1,639 million (YoY +149.9%)
- Anime and visual content businessNet Sales¥14,477 million (YoY +47.7%)Operating profit¥1,758 million (YoY +107.4%)
- Other BusinessNet Sales¥2,290 million (YoY +37.2%)Operating profit¥81 million
Interim net profit
¥1,597 million+84.8%
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | ¥73,520 million (YoY +14.8%) |
| Operating profit | ¥3,478 million (YoY +210.8%) |
| Ordinary income | ¥3,621 million (YoY +172.9%) |
| Net income | ¥1,597 million (interim net income attributable to owners of the parent) (YoY +84.8%) |
| Gross Profit Margin | 29.7 |
| Operating profit margin | 4.7 |
| Selling, general and administrative expenses | ¥18,336 million |
| Full-year earnings forecast | Net Sales Not disclosed / Operating profit ¥6,000 million / Profit attributable to owners of the parent ¥3,200 million |
| Self-assessment against the plan | Progressing steadily |
| Segment results | Segment Music business / Net Sales ¥57,927 million (YoY +8.3%) / Operating profit ¥1,639 million (YoY +149.9%), Segment Anime and visual content business / Net Sales ¥14,477 million (YoY +47.7%) / Operating profit ¥1,758 million (YoY +107.4%), Segment Other Business / Net Sales ¥2,290 million (YoY +37.2%) / Operating profit ¥81 million |
| Breakdown of Factors Affecting the Change | Factors Increase in revenue / Amount ¥9,492 million, Factors Increase in cost of sales / Amount ¥5,625 million, Factors Increase in gross profit / Amount ¥3,866 million, Factors Higher SG&A Expenses / Amount ¥1,506 million, Factors Increase in personnel expenses / Amount ¥386 million, Factors Decrease in promotional and advertising expenses / Amount ¥-138 million, Factors Increase in general expenses / Amount ¥1,259 million |
| Key KPIs | Indicator name Total number of performances / Value 648 performances / Year on year against the same period last year 65 performances, Indicator name Attendance / Value 179 10,000 people / Year on year against the same period last year 30 10,000 people, Indicator name Albums sold / Value 887 thousand prescriptions / Year on year against the same period last year -221 thousand prescriptions, Indicator name Singles sold / Value 3,222 thousand prescriptions / Year on year against the same period last year 741 thousand prescriptions, Indicator name DVDs/Blu-rays sold / Value 839 thousand prescriptions / Year on year against the same period last year -67 thousand prescriptions |
| Unit price and quantity metrics | Indicator name Average ticket price / Value 12,188 yen / Year on year against the same period last year -914 yen, Indicator name Average album price / Value 2,441 yen / Year on year against the same period last year 443 yen, Indicator name Albums sold / Value 887 thousand prescriptions / Year on year against the same period last year -221 thousand prescriptions, Indicator name Music package and single-unit price / Value 5,833 yen / Year on year against the same period last year 583 yen, Indicator name Number of music packages and singles / Value 3,222 thousand prescriptions / Year on year against the same period last year 741 thousand prescriptions |
| New initiatives | Launch of a global music catalog acquisition project with a total value of approximately USD 100 million, Additional acquisition of an interest in US artist management company S10 Entertainment & Media, Major performances and major productions scheduled for the second half of the fiscal year |
| Interim net profit | ¥1,597 million (YoY +84.8%) |
Items this document does not state (15)
Results for the three months of the current quarterProgress against full-year forecastNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Increased merchandise sales, strong sales of packaged works, strong performance by major live-action films, increased revenue across each segment, optimization of selling, general and administrative expenses, and a review of the organizational structure and structural reforms at Asian subsidiaries in the Other Businesses segment.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.